drugset / Trial / NCT03996655

Different Reversal Agents in Pediatric Day-case Cancer Surgery

NCT03996655

Phase 4 Unknown 80 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study was to compare the efficacy of sugammadex and neostigmine on reversing neuromuscular blockers in pediatric patients undergoing outpatient surgical procedures.

Timeline

Start
2019-06
Primary completion
2019-09
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.05 mg/kg Intravenous
Subject Sugammadex Other / unclassified 2 mg/kg Intravenous